ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SUPN Supernus Pharmaceuticals Inc

25.99
-0.57 (-2.15%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 152.51M170.05M177.35M167.84M155.41M134.77M154.34M164.52M
Operating Income 1.97M11.35M-1.52M32.44M5.18M-17.59M8.14M-996k
Pre Tax Income 14.72M11.32M-444k35.14M9.02M-17.13M9.89M990k
Net Income 25.62M7.87M1.75M25.48M16.95M-831k-15.98M1.18M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 1.97M11.35M-1.52M32.44M5.18M-17.59M8.14M-996k
EBITDA 23.33M32.67M19.92M53.85M25.78M3.14M30.03M40.84M
Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 215M302.24M408.9M392.76M520.4M586.31M667.75M609.04M
Operating Income 54.22M99.54M144.44M148.57M173.7M86.03M46.12M-5.27M
Pre Tax Income 50.37M100.62M140.18M147.49M168.65M73.18M60.74M2.77M
Net Income 91.22M57.28M110.99M113.06M126.95M53.42M60.71M1.32M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 1.8251.1162.1222.1522.4011.0031.1190.024
EBIT 53.53M99.25M144.44M148.57M173.7M86.03M46.12M-5.27M
EBITDA 56.62M107.64M151.54M155.23M193.7M118.62M131.67M99.78M